Emiltatug Ledadotin (Emi-Le) Granted Breakthrough Therapy Designation by the U.S. FDA for Adenoid Cystic Carcinoma (ACC)

Servier today announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to ...
BMJ Case Reports

Ovarian torsion presenting as massive oedema: diagnostic challenges and fertility-preserving management

Massive ovarian oedema (MOE) is a rare benign condition that can mimic ovarian neoplasms and lead to unnecessary oophorectomy ...

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

The Company intends to submit a Biologics License Application (BLA) for TARA-002 in Lymphatic Malformations (LMs) in 2H 2027Hosting virtual ...

NextCure Provides Business Update and Reports First Quarter 2026 Financial Results

SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 ...

Krystal Biotech: Vyjuvek Is Not The Primary Asset

Krystal Biotech leverages its HSV-1 gene delivery platform, with VYJUVEK generating strong cash flow. Read why I rate KRYS ...
Targeted Oncology

FDA Grants Breakthrough Therapy Designation to Emiltatug Ledadotin for Adenoid Cystic Carcinoma

Breakthrough therapy designation targets an unmet-need ACC population, positioning B7-H4 as a therapeutically actionable antigen in solid histology or high-grade transformed disease. Dose-escalation ...

Pensioners claiming new disability benefit could receive first payment this month

Pensioners with any of these 10 health conditions could get up to £458 a month READ MORE: Pension Age Disability Payment ...
News-Medical.Net

Cedars-Sinai develops AI tool for faster and cheaper tumor analysis

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...